 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
The HIV Vaccine Effort by CompanyDecember 1996
Listed in order of estimated size of overall 1996 R&D
expenditures*
Vaccine Approaches: S=subunit, P=peptide, PV=pseudovirion, LV=live vector, D=DNA, M=mucosal, WK=whole killed * Information from 1995 Lehman Brothers and 1995 Bioscan analyses. ** R&D and Sales: $$$$$: more than $1 billion $$$: $100 million to $1 billion $: less than $100 million. This article was provided by AIDS Vaccine Advocacy Coalition. It is a part of the publication Industry Investment in HIV Vaccine Research. Visit AVAC's website to find out more about their activities and publications.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
